Litcius/Paper detail

Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease

Paul W. Buehler, Delaney Swindle, David I. Pak, Scott K. Ferguson, Susan M. Majka, Vijaya Karoor, Radu Moldovan, Chantal Sintas, Jennifer Ann Black, Thomas Gentinetta, Raphael M. Buzzi, Florence Vallelian, Andreas Wassmer, Monika Edler, Joseph Bain, Daniel J. Schu, Kathryn L. Hassell, Rachelle Nuss, Dominik J. Schaer, David Irwin

2021Free Radical Biology and Medicine26 citationsDOIOpen Access PDF

Topics & Concepts

HemopexinMedicinePulmonary hypertensionInternal medicineHypoxia (environmental)PathophysiologyCardiologyLungHypoxic pulmonary vasoconstrictionPathologyHemeBiologyBiochemistryEnzymeOrganic chemistryChemistryOxygenHemoglobinopathies and Related DisordersHeme Oxygenase-1 and Carbon MonoxideIron Metabolism and Disorders
Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease | Litcius